(RHI) Robert Half International - Ratings and Ratios

Robert Half Inc. (NYSE: RHI) is a global leader in talent solutions and business consulting, operating through three core segments: Contract Talent Solutions, Permanent Placement Talent Solutions, and Protiviti. The company specializes in matching skilled professionals with businesses across finance, accounting, technology, marketing, legal, and administrative fields. Its Contract Talent Solutions segment places professionals in short-term or project-based roles, while the Permanent Placement segment focuses on filling full-time positions. The Protiviti segment provides consulting services in risk management, internal audit, compliance, and digital transformation.

Founded in 1948 and headquartered in Menlo Park, California, Robert Half Inc. operates under multiple brands, including Accountemps, Robert Half Finance and Accounting, OfficeTeam, and The Creative Group. The company serves clients and candidates across the United States and internationally. In July 2023, it changed its name from Robert Half International Inc. to Robert Half Inc., reflecting its streamlined brand identity. With a market capitalization of $4.724 billion, the company is a key player in the Human Resource & Employment Services industry, offering a range of services tailored to evolving workforce demands.

3-month forecast: Based on and , RHI is expected to face short-term headwinds due to its current price (44.01) trading below its 20-day (48.90) and 50-day (53.19) moving averages, signaling bearish momentum. The average true range (ATR) of 2.19 suggests moderate volatility. However, its forward P/E of 18.12, slightly below the current P/E of 18.95, indicates investor expectations of stable earnings. The price-to-sales ratio of 0.82 and return on equity of 18.26% highlight its reasonable valuation and profitability. Support levels are likely to form near 40-42, while resistance could emerge at 48. A breakout above 48 may signal a recovery, while a breakdown below 40 could trigger further declines.